| |
|
|
| |
You are here: Home: BCU NSABP Symposium : PowerPoint Presentations |
|
| |
|
|
| |
 |
| FACULTY |
|
 |
Edward H Romond, MD
Professor of Medicine
Division of Hematology/Oncology
Markey Cancer Center
University of Kentucky
Lexington, Kentucky |
|
B-31/N9831
First Interim Joint Analysis |
| |
 |
|
|
 |
Dennis J Slamon, MD, PhD
Professor of Medicine
Chief, Division of Hematology/Oncology
Director of Clinical/Translational Research
Jonsson Comprehensive Cancer Center
David Geffen School of Medicine at UCLA
Los Angeles, California |
|
BCIRG006 Phase III Trial |
| |
|
|
|
 |
Brian Leyland-Jones, MD, PhD
Minda de Gunzburg Professor
Department of Oncology
McGill University
Montreal, Quebec |
HERA: Key Design Elements, Results
and Future Plans |
| |
|
|
|
 |
Peter A Kaufman, MD
Associate Professor of Medicine
Section of Hematology/Oncology
Dartmouth-Hitchcock Medical Center
Comprehensive Breast Care Program
Norris Cotton Cancer Center
Lebanon, New Hampshire |
|
NCCTG N9831
May 2005 Update |
| |
|
|
|
 |
Charles E Geyer Jr, MD
Director of Medical Affairs
National Surgical Adjuvant Breast and
Bowel Project
Director of Breast Medical Oncology
Allegheny General Hospital
Pittsburgh, Pennsylvania |
| |
Cardiac Toxicity on
NSABP B-31 |
| |
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
